Clinical Benefit of Pembrolizumab in Advanced Urothelial Cancer Patients in Real-Life Setting: An Efficacy and Safety Monocentric Study

Background: Pembrolizumab is approved for patients with metastatic urothelial carcinoma (UC) who progressed under platinum therapy. The aim of this study was to assess the efficacy and safety of pembrolizumab in a cohort of real-life UC patients. Methods: This retrospective, observational study incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Dang, Elodie, Vallée, Alexandre, Lepage-Seydoux, Coralie, Sejean, Karine, Bonan, Brigitte, Abraham, Christine, Beuzeboc, Philippe, Ratta, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870973/
https://www.ncbi.nlm.nih.gov/pubmed/35200579
http://dx.doi.org/10.3390/curroncol29020080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870973/
https://www.ncbi.nlm.nih.gov/pubmed/35200579
http://dx.doi.org/10.3390/curroncol29020080

Ejemplares similares